CCMB-Kerala’s Arya Vaidya Sala agreement to assess Ayurveda’s efficacy against COVID-19

The centuries old tried-and-proven Indian Ayurveda science is being tapped for potential formulation to fight coronavirus. In a very interesting development, the CSIR (Council of Scientific & Industrial Research) and CCMB (Centre for Cellular and Molecular Biology), Hyderabad, has entered into an agreement with Kerala-based Arya Vaidya Sala (AVS), Kottakkal, to check the efficacy of Ayurvedic formulations in the fight against coronavirus SARS-CoV-2.

AVS is a 118-years old charitable institution headquartered at Kottakkal in Kerala, which has been engaged in the practice and propagation of Ayurveda. They manufacture more than 500 formulations. CCMB is a premier life science research institute and have been testing, sequencing and growing coronavirus strains in their labs.

In this partnership, AVS will provide standardised Ayurveda formulations. CCMB will test them on the lab-grown coronavirus strains in cell culture system, and check for their anti-viral efficacy.

Exit mobile version